Skip to main content

Advertisement

Table 1 Selected patients- and disease characteristics of the total study cohort with univariable analyses of BB-CAM use

From: Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy

CHARACTERISTICS ALL PATIENTS BB-CAM p 1
   User Non-user
Total Count % of all patients Count % of Total Count % of Total
448 100% 332 74.1% 116 25.9%
Patients
 Age in years (mean ± SD)   62.2 ± 12.4 61.5 ± 12.5 64.1 ± 12.1 0.378
≤60 yrs. 193 43.1% 154 79.8% 39 20.2% 0.017
>60 yrs. 255 56.9% 77 30.2% 178 69.8%
Disease 0.168
 Breast-Ca Early Stage 147 32.8% 114 77.6% 33 22.4%  
Advanced 201 44.9% 141 70.1% 60 29.9%  
Recurrence 13 2.9% 9 69.2% 4 30.8%  
 Ovarian-Ca FIGO I-III 23 5.1% 21 91.3% 2 8.7%  
FIGO IV 15 3.3% 9 60.0% 6 40.0%  
Recurrence 37 8.3% 30 81.1% 7 18.9%  
 Other Gyn-Ca   12 2.7% 8 66.7% 4 33.3%  
 Disease state Early Stage 171 38.2% 135 78.9% 36 21.1% 0.066
Advanced+ Recurrence 277 61.8% 197 71.1% 80 28.9%
  1. 1p values are not adjusted for multiplicity and have to be interpreted to be exploratory